
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Adani Group has announced a massive Rs 2 lakh crore annual greenfield capital expenditure plan for the next five years, targeting significant expansion across its ports, energy, and logistics verticals.
Indian equity markets witnessed a sharp decline on March 13, 2026, with the Sensex falling 1,471 points and Nifty dropping below 23,200 amid global pressures.
Ramky Infrastructure's subsidiary has secured a 95-year concession agreement with MIDC to develop a ₹3,000 crore high-tech pharmaceutical park in Raigad, Maharashtra.
India is reportedly set to scrap financial bids for a majority stake in IDBI Bank after offers from potential buyers failed to meet the government's minimum valuation.
Bajel Projects Ltd has secured a significant EPC order valued over Rs. 400 crore from PGCIL to construct a critical 765kV transmission line in India.
A detailed overview of EMA India Ltd.'s key board meetings in 2025, covering financial results, asset sales, and the strategic relocation of its registered office.
Former U.S. President Donald Trump acknowledges that Russia may be providing some assistance to Iran, drawing parallels to American support for Ukraine amid the ongoing conflict.
Indian equity benchmarks Sensex and Nifty plummeted for a third straight day, erasing over ₹19 lakh crore in investor wealth amid rising oil prices and geopolitical tensions.
Vedanta's demerger into five listed entities, approved by NCLT, is set for completion by March 2026 to unlock value and focus on core business growth.
India's foreign exchange reserves fell by $11.68 billion to $716.81 billion due to the RBI selling dollars to support the rupee amid global pressures.
India's foreign exchange reserves saw their largest drop since November 2024 as the RBI intervened heavily to support the rupee, which hit a record low due to soaring oil prices from the Iran war.
India's foreign exchange reserves fell by $11.68 billion to $716.81 billion in early March 2026, driven by RBI intervention to support the rupee.
Dr. Reddy's Laboratories has stopped its Phase III trial for the lung cancer drug eftilagimod alfa following a recommendation, causing its stock to decline.
Goldman Sachs and Fitch Ratings present differing forecasts for India's GDP growth for 2026 and 2027, citing varied factors from trade deals to domestic demand.
Global crude oil prices surged past $100 per barrel following supply disruptions in Iraq, causing a sharp correction in Indian equity markets and a record low for the rupee.
Indian stock markets experienced their worst week in years as surging crude oil prices above $100, a record-low rupee, and geopolitical tensions triggered a massive sell-off.